CIK 0001770787
- Large accelerated filer
10x Genomics, Inc.
Sign in to watch- Ticker
- TXG
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455614458
- Phone
- +1 925-401-7300
- Business address
- 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,605,538
- in 10 filings, $6.3M under 10b5-1 plans
Net −$12,605,538. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-24 | Hindson Benjamin J. Director | Exercise or conversion · Stock Option (right to buy) | −28,000 | 172,000 | ||
| 2020-12-23 | McAnear Justin J. Chief Financial Officer | Exercise or conversion | +19,841 | $5.04 | $100K | 20,774 |
| 2020-12-23 | McAnear Justin J. Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −19,841 | 480,159 | ||
| 2020-12-22 | Saxonov Serge Chief Executive Officer | Exercise or conversion | +2,667 | $1.07 | $3K | 879,506 |
| 2020-12-22 | Saxonov Serge Chief Executive Officer | Exercise or conversion | +962 | $1.20 | $1K | 880,468 |
| 2020-12-22 | Saxonov Serge Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −2,667 | 0 | ||
| 2020-12-22 | Saxonov Serge Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −962 | 108,898 | ||
| 2020-12-16 | STUELPNAGEL JOHN R Director | Sale | −1,101 | $146.78 | $162K | 494,890 |
| 2020-12-16 | STUELPNAGEL JOHN R Director | Sale | −2,200 | $147.68 | $325K | 492,690 |
| 2020-12-16 | STUELPNAGEL JOHN R Director | Sale | −3,098 | $148.50 | $460K | 489,592 |
| 2020-12-16 | STUELPNAGEL JOHN R Director | Sale | −801 | $149.35 | $120K | 488,791 |
| 2020-12-16 | STUELPNAGEL JOHN R Director | Sale | −300 | $151.24 | $45K | 488,491 |
| 2020-12-14 | Saxonov Serge Chief Executive Officer | Gift | −15,000 | 89,960 | ||
| 2020-12-14 | Saxonov Serge Chief Executive Officer | Gift | +15,000 | 876,839 | ||
| 2020-12-10 | Saxonov Serge Chief Executive Officer | Gift | −104,960 | 861,839 | ||
| 2020-12-10 | Saxonov Serge Chief Executive Officer | Gift | +104,960 | 104,960 | ||
| 2020-12-10 | Venrock Associates VI, L.P. 10% owner | Other disposition | −268,692 | 2,037,825 | ||
| 2020-12-10 | ROBERTS BRYAN E Director | Other disposition | −268,692 | 2,037,825 | ||
| 2020-12-10 | ROBERTS BRYAN E Director | Other acquisition | +93,487 | 215,291 | ||
| 2020-12-08 | Venrock Associates VI, L.P. 10% owner | Conversion | +3,000,000 | 3,037,825 |
Page 51 of 57 · 1,128 trades